Pursuant to Regulation 30 of the Listing Regulations, please find enclosed Press Release on the Un-Audited Financial Results (Standalone & Consolidated) for the quarter and nine months ended 31st December, 2025.

pdf

Wockhardt Ltd.

10 Feb 2026

1394.80

0.86%

Result

Wockhardt Ltd - 532300 - Board Meeting Outcome for Outcome Of The Board Meeting

BSE India

Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''Listing Regulations'); and in continuation to our letter bearing reference no: WOCK/SEC/SE/2025-26/065 dated 4th February, 2026, we wish to inform you that the Board of Directors of the Company, at its meeting held today i.e.10th February, 2026, inter-alia, has approved the Un-Audited Financial Results (Standalone & Consolidated) for the quarter and nine months ended 31st December, 2025.

pdf

	Dec 2025	Sep 2025	Dec 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	913.00	803.00	729.00	13.7%	25.2%
Operating Profit Qtr	177.00	178.00	128.00	-0.6%	38.3%
Net Profit Qtr	59.00	78.00	14.00	-24.4%	321.4%
Earning Per Share Adjusted latest Qtr	3.63	4.80	0.86	-24.4%	322.1%

* Consolidated data

Detailed Results

Wockhardt Ltd.

04 Feb 2026

1394.80

0.86%

Board Meeting

Wockhardt Ltd - 532300 - Board Meeting Intimation for Intimation Of The Meeting Of Board Of …

BSE India

Wockhardt Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2026 ,inter alia, to consider and approve Pursuant to Regulation 29(1) of SEBI (LODR) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the Company will be held on Tuesday, 10th February, 2026, inter alia, to consider and approve the Un-audited Financial Results (Standalone & Consolidated) of the Company for the quarter and nine months ended 31st December, 2025.

pdf

Wockhardt Ltd.

03 Feb 2026

1394.80

0.86%

Company Update

Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

In terms of provisions of Regulation 30 (read with Part A of Schedule III) and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''Listing Regulations'') we wish to inform you that, Dr. Sanjeev Kumar Sharma, President- Manufacturing, Quality & R&D, designated as Senior Management Personnel (SMP) of the Company, has tendered his resignation from the services of the Company effective from close of business hours of 2nd February, 2026 due to personal reasons and consequently shall cease to be SMP of the Company

pdf

Wockhardt Ltd.

27 Jan 2026

1394.80

0.86%

Company Update

Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Pursuant to Regulation 30 0f Listing Regulations, please find enclosed Press Release- "Wockhardt''s Fifth Novel Antibiotic, Foviscu (WCK 4282), Matches Gold Standard Meropenem in pivotal Phase 3 Trial as First-Line Therapies Fail Against Rising Resistance.":

pdf

Wockhardt Ltd.

16 Jan 2026

1394.80

0.86%

Company Update

Wockhardt Ltd - 532300 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure …

BSE India

Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015 read with SEBI Master Circular SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, we wish to inform you that CFC Finlease Private Limited, a SEBI - Licensed ESG rating provider, has voluntarily assigned an ESG rating of 70 for the year 2025 as part of its ESG assessement process.

pdf

Wockhardt Ltd.

08 Jan 2026

1394.80

0.86%

Company Update

Wockhardt Ltd - 532300 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, please find enclosed the Certificate received from MUFG Intime India Private Limited, Registrar and Share Transfer Agent of the Company for the quarter ended 31st December, 2025.

pdf

Wockhardt Ltd.

07 Jan 2026

1394.80

0.86%

Company Update

Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Pursuant to Regulation 30 of Listing Regulations, please find enclosed Press Release- "Wockhardt Files Marketing Authorisation Application for WCK 5222 with European Medicines Agency".

pdf

Is Wockhardt Ltd. worth buying?

460 Votes:

Buy 73.48%

Sell 17.17%

Hold 9.35%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Results Update SEE REPORTS >

pdf